(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. Inhibition of XNF-ATc3 blocks CE in neural plate explants.
(A) Neural plate explants from stage 12-12.5 were cultured and
photographed hourly. Upper panels show a control neural plate explant. The
middle panels show a neural plate explant of an embryo injected with 2 ng
DN XNF-ATc3 and 200 pg GFP. The lower panels show GFP
fluorescence. The upper graph illustrates the change in length (
L) and
the change in width (
W) over time. The lower graph shows the change in
neural tube length (
NT) between 2 and 4 hours. Stars indicate where the
DN XNF-ATc3 injected explants are significantly different than the
controls in an unpaired Student's t-test. (B) Neural plate
explants incubated in 400 nM CsA (lower panels). As a vehicle control, neural
plate explants were incubated in 0.33% ethanol (upper panels). The graph
describes the change in length (
L) and change in width (
W) over
time. Stars indicate where the CsA-treated explants were significantly
different from the control and ethanol treated explants using an unpaired
Student's t-test. (C) CsA treatment does not lead to cell fate
changes in neural plate explants. In situ hybridization using antisense probes
for XAG-1, Krox20 and HoxB9. Left panel shows two control
embryos used to stage the explants (left, posterior view; right, anterior
view). Middle panel presents control neural plate explants, while the right
panel shows explants incubated in 400 nM CsA.